Biotech

All Articles

Lilly articles extra beneficial records on its own once a week insulin prospect

.On the heels of an FDA denial for its main rivalrous Novo Nordisk, Eli Lilly is actually making hea...

IN 8bio halts period 2 test, gives up fifty percent of workforce

.Just a handful of months after application the initial individual in a period 2 test for recently i...

Lilly, Haya ink $1B biobuck weight problems deal to explore darker genome

.Eli Lilly's look for obesity targets has led it to the dark genome. The Big Pharma has crafted an o...

ArsenalBio raises $325M, turns out of previous lead resource

.Arsenal Biosciences is proceeding up. The cell therapy firm has actually added $325 thousand in amm...

Lilly- backed effective weight loss biotech files IPO

.After increasing $170 thousand back in February, metabolic disease-focused BioAge Labs has filed to...

Aelis' cannabis make use of drug flunks stage 2b, driving Indivior to review $100M possibility

.Aelis Farma's hopes of protecting an easy, beneficial selection on a $100 million option payment ha...

ProKidney stops stage 3 test not needed for tissue treatment authorization

.ProKidney has ceased among a pair of stage 3 tests for its own cell treatment for renal disease aft...

Vaxcyte rises on 'remarkable' 31-valent PCV succeed against Pfizer

.Vaxcyte revealed what professionals called "remarkable" phase 1/2 information for its 31-valent pne...

Recursion's brain health condition trial reveals insufficient documentation of efficiency

.Recursion has discovered via an early examination of its own tech-enabled strategy to medicine disc...

Acepodia, Pfizer click on together for chemistry-based tissue therapy

.Call it a situation of really good chemical make up: Acepodia, a biotech based upon Nobel Prize-win...